CDISC Names Industry Veteran David A. Evans President and CEO

Ann P. White

CDISC Names Industry Veteran David A. Evans President and CEO

Austin, TX – 17 December 2020 – CDISC announced that industry veteran David A. Evans will join the organization as its new President and Chief Executive Officer effective January 1, 2021. Dave brings over 35 years’ experience serving in various executive-level positions in software development, clinical research, regulatory and healthcare industries. He is recognized industry-wide as a leading technology visionary for developing and implementing complex process and system solutions and as an expert in the areas of information standards, regulatory compliance and quality governance. The architect and developer of the first electronic drug submission to the US FDA in 1985, Dave has been responsible for more than 100 electronic regulatory submissions and complex clinical data warehouse systems.

Dave joins CDISC after an eight-year tenure at Accenture where he was the Principal Director, Global Head of Quality Governance and Regulatory Compliance for Accenture Life Science. Prior to that, he was CIO of Octagon Research Solutions, which was acquired by Accenture.

Dave previously served as Chair of the CDISC Advisory Council and as a member of the CDISC Board of Directors.

“Dave’s extensive clinical data expertise and strong industry relationships, combined with his passion for integrating technology and standards, bring a unique expertise to CDISC. We are excited about Dave taking the helm as the organization moves quickly toward a more technology-based standards future and cultivates deeper relationships with stakeholders throughout the clinical research ecosystem,” stated Jonathan Zung, PhD, Chair of the CDISC Board of Directors.

In accepting the appointment, CDISC’s new President and CEO said, “I am honored by the CDISC Board and the CDISC organization for this opportunity to lead and build on the great work and advances that CDISC has brought to the industry over the last 20 years. CDISC standards are an integral part of all aspects of clinical research – information collection, processing, analysis, reporting and regulatory authority submissions. Under my leadership, the CDISC team will continue the advancement of scientific information exchange through the design, development and promotion of data and metadata standards and work closely with our global community to drive more meaningful clinical research.”

Dave received his MS in Biomedical Engineering from Drexel University and his BS in Biology from Ursinus College.


CDISC creates clarity in clinical research by convening a global community to develop and advance data standards of the highest quality. Required by the United States Food and Drug Administration (FDA) and Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA) and adopted by the world’s leading research organizations, CDISC standards enable the accessibility, interoperability, and reusability of data. With the help of CDISC standards, the entire research community can maximize the value of data for more efficient and meaningful research that has invaluable impact on global health. CDISC is a 501(c)(3) global nonprofit charitable organization with administrative offices in Austin, Texas, with hundreds of employees, volunteers, and member organizations around the world.